New antibacterial candidates against Acinetobacter baumannii discovered by in silico-driven chemogenomics repurposing
Table 2
Tavaborole’s minimum inhibitory concentration (MIC, g/ml) against ATCC 19606 strain and 14 MDR Acinetobacter baumannii clinical isolates.